NJ
Neville James Fielke
About Neville James Fielke
Data last updated:
Neville James Fielke is a Director at Mycelium Sona Biotech Private Limited (since 2021). The company operates in Life Sciences. Mycelium Sona Biotech Private Limited reported revenue of ₹1.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Aug 2021 | 2021 | ₹1.75 Cr (FY 2025) | Active |
Board colleagues of Neville James Fielke
| Name | DIN | Company | Designation |
|---|---|---|---|
| Donald Charles Brumley | 09258791 | Mycelium Sona Biotech Private Limited | Director |
| Muralidhar Padmanabha Rao | 03530287 | Mycelium Sona Biotech Private Limited | Director |
| Valliappa Chockalingam | 01753052 | Mycelium Sona Biotech Private Limited | Director |
| William Hush Allan Scott | 09257128 | Mycelium Sona Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neville James Fielke
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neville James Fielke
Neville James Fielke currently holds 1 directorship: Mycelium Sona Biotech Private Limited (Director, since 13 Aug 2021, revenue ₹1.75 Cr (FY 2025)).
Neville James Fielke was first appointed on 13 Aug 2021 as Director at Mycelium Sona Biotech Private Limited.
The current boards of Neville James Fielke's companies include Donald Charles Brumley (Mycelium Sona Biotech Private Limited), Muralidhar Padmanabha Rao (Mycelium Sona Biotech Private Limited), Valliappa Chockalingam (Mycelium Sona Biotech Private Limited), William Hush Allan Scott (Mycelium Sona Biotech Private Limited).